arrow
S

Sophia Koo

Brigham and Women's Hospital
H指数:35
被引数:5,072

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An Open-Label Phase II Trial of Sotrovimab (VIR-7831) Prophylaxis Against COVID-19 Infection in Immunocompromised Individuals with Impaired SARS-CoV-2 Humoral Immunity

一项关于Sotrovimab(VIR-7831)预防COVID-19感染的开放标签II期临床试验,研究对象为SARS-CoV-2体液免疫受损的免疫抑制个体

2025-08-080
OAAI
Urine Cell-Free RNA vs Plasma Cell-Free RNA for Monitoring of Kidney Injury and Immune Complications

尿液游离RNA与血浆游离RNA在肾脏损伤及免疫并发症监测中的比较

2025-08-010
OAAI
Population-based longitudinal study over two decades of Candida and Candida-like species bloodstream infection reveals gender and species differences in mortality, recurrence and resistance

一项为期二十年的基于人群的纵向研究揭示了念珠菌及念珠菌样菌种血流感染在死亡率、复发和耐药性方面的性别与菌种差异。

2025-05-220
OA
Modeling Invasive Aspergillosis Risk for the Application of Prophylaxis Strategies

建立侵袭性曲霉病风险模型以应用预防策略

2024-02-067
OAAI
A consensus conference to define the utility of advanced infectious disease diagnostics in solid organ transplant recipients
2022-12-0123
OA